Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ClearPoint Neuro Inc. - Common Stock
(NQ:
CLPT
)
13.93
+1.10 (+8.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ClearPoint Neuro Inc. - Common Stock
ClearPoint Neuro Reports First Quarter 2025 Results
May 13, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
May 12, 2025
Via
ACCESS Newswire
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
April 28, 2025
Via
ACCESS Newswire
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
April 25, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
April 24, 2025
Via
ACCESS Newswire
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
February 26, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
November 13, 2024
Via
ACCESSWIRE
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
February 14, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
February 12, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
January 27, 2025
Via
ACCESS Newswire
ClearPoint Neuro Reports Third Quarter 2024 Results
November 07, 2024
Via
ACCESSWIRE
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024
October 31, 2024
Via
ACCESSWIRE
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
May 24, 2023
From
ClearPoint Neuro, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.